KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Exchange Rate Effect (2016 - 2025)

Globus Medical (GMED) has disclosed Exchange Rate Effect for 15 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 194.3% year-over-year to $4.0 million, compared with a TTM value of $22.4 million through Dec 2025, up 8701.96%, and an annual FY2025 reading of $22.4 million, up 8701.96% over the prior year.
  • Exchange Rate Effect was $4.0 million for Q4 2025 at Globus Medical, up from $512000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $14.4 million in Q2 2025 and bottomed at -$4.3 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $1.2 million, with a median of $6000.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect soared 1160.53% in 2022, then plummeted 12638.46% in 2024.
  • Year by year, Exchange Rate Effect stood at -$240000.0 in 2021, then crashed by 249.58% to -$839000.0 in 2022, then surged by 58.64% to -$347000.0 in 2023, then plummeted by 1132.85% to -$4.3 million in 2024, then skyrocketed by 194.3% to $4.0 million in 2025.
  • Business Quant data shows Exchange Rate Effect for GMED at $4.0 million in Q4 2025, $512000.0 in Q3 2025, and $14.4 million in Q2 2025.